News Articles and Montana BioScience Alliance Newsletters
Extends patent protection for Microbion’s proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039.
News, events, and SBIR/STTR Solicitations for May
A scientific team that includes University of Montana biologist Mark Grimes recently used artificial intelligence to better understand how protein groups in lung cancer cells regulate cell division and metabolism. The work may lead to greater understanding of lung cancer vulnerabilities and future anti-cancer therapies.
Viral clearance testing is a critical step in the development and production of biologics and other products that are derived from biological sources. GMP-compliant service provides the assurance that products have been thoroughly tested for the presence of viral contaminants, and that they are safe for use.
Scientists at the McLaughlin Institute are spearheading this patient registry which allows the Institute to enroll Montanans in potential clinical trials and research studies.
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.
As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.
Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR
Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.
Updates from product development and small business programs
View the Winter II 2024 Newsletter now!
View the Winter 2023 Newsletter now!